Notice2025-04429
National Institute on Drug Abuse; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 18, 2025
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 51 (Tuesday, March 18, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 51 (Tuesday, March 18, 2025)]
[Notices]
[Pages 12540-12541]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-04429]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, NIDA. The meeting will be closed to the public as indicated
below in accordance with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for the review, discussion, and
evaluation of individual intramural programs and projects conducted by
the National Institute on Drug Abuse, including consideration of
personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIDA.
Date: May 06, 2025.
Time: 10:00 a.m. to 4:45 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Meeting Format: Virtual Meeting.
Place: National Institute on Drug Abuse, NIH, Biomedical
Research Center, 251 Bayview Boulevard, Baltimore, MD 21224.
Contact Person: Megan E. Bollinger, M.S., Management Analyst,
Office of the Scientific Director, National Institute on Drug Abuse,
251 Bayview Boulevard, Suite 200, Baltimore, MD 21224, (667) 312-
5035 email: <a href="/cdn-cgi/l/email-protection#feb39b999f90d0bc9192929790999b8cbe909796d0999188"><span class="__cf_email__" data-cfemail="0c41696b6d62224e63606065626b697e4c626564226b637a">[email protected]</span></a>
Contact Person: Deon Harvey, Ph.D., Management Analyst, Office
of the Scientific Director, National Institute on Drug Abuse, 251
Bayview Boulevard, Suite 200, Baltimore, MD 21224, (667) 312-5568,
email: <a href="/cdn-cgi/l/email-protection#84c0e1ebeaaacce5f6f2e1fdc4eaedecaae3ebf2"><span class="__cf_email__" data-cfemail="783c1d17165630190a0e1d0138161110561f170e">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction
[[Page 12541]]
Research Programs, National Institutes of Health, HHS)
Dated: March 13, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-04429 Filed 3-17-25; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 18, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.